VIB developed VHH technology for oral delivery
- Therapeutic antibodies for oral ingestion to reach gastrointestinal targets
- Set up of a scalable, cost-effective microbial production process
POC in piglets, protected against ETEC infection
- Together with Eric Cox (UGent Faculty of Veterinary Medicine)
- Reduces need for antibiotics
VIB-UGent labs of Nico Callewaert & Ann Depicker, VIB-VUB lab of Henri De Greve
New spin-off Animab (°2020)
- To bring product to the market
- Seed round of 3.4 M€ led by Seventure Partners & PMV
- with participations of Agri Investment Fund, V-Bio Ventures & VIB
